Oncolytics Biotech (ONCY)
NASDAQ:ONCY
Holding ONCY?
Track your performance easily

Oncolytics Biotech (ONCY) Financial Statements

1,171 Followers

Oncolytics Biotech Financial Overview

Oncolytics Biotech's market cap is currently ―. The company's EPS TTM is $-0.283; its P/E ratio is -4.17; Oncolytics Biotech is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -7.16MC$ -6.89MC$ -3.91MC$ -9.92MC$ -7.39M
EBITDAC$ -6.94MC$ -6.77MC$ -3.80MC$ -9.81MC$ -7.30M
Net Income Common StockholdersC$ -7.26MC$ -6.89MC$ -3.95MC$ -9.93MC$ -7.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 24.85MC$ 29.60MC$ 34.91MC$ 39.98MC$ 24.35M
Total AssetsC$ 32.07MC$ 34.75MC$ 38.82MC$ 46.09MC$ 31.97M
Total DebtC$ 1.12MC$ 1.13MC$ 423.00KC$ 514.00KC$ 479.00K
Net DebtC$ -23.73MC$ -28.48MC$ -34.49MC$ -39.47MC$ -23.87M
Total LiabilitiesC$ 13.76MC$ 11.78MC$ 11.26MC$ 17.07MC$ 9.73M
Stockholders EquityC$ 18.31MC$ 22.97MC$ 27.56MC$ 29.02MC$ 22.24M
Cash Flow-
Free Cash FlowC$ -14.49MC$ -7.51MC$ -6.13MC$ -6.03MC$ -8.46M
Operating Cash FlowC$ -14.29MC$ -7.47MC$ -6.12MC$ -6.03MC$ -8.46M
Investing Cash FlowC$ -201.00KC$ -46.00KC$ -3.00KC$ 6.77MC$ 6.79M
Financing Cash FlowC$ 3.47MC$ 1.50MC$ 1.74MC$ 21.29MC$ 3.69M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

Oncolytics Biotech Debt to Assets

Oncolytics Biotech Cash Flow

Oncolytics Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis